{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:12:42Z","timestamp":1795201962402,"version":"4.10.3"},"reference-count":41,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T00:00:00Z","timestamp":1268352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>This study investigated the cytotoxicity and mechanism of action of AS703026, a novel, selective, orally bioavailable MEK1\/2 inhibitor, in human multiple myeloma (MM). AS703026 inhibited growth and survival of MM cells and cytokine\u2010induced osteoclast differentiation more potently (9\u2010 to 10\u2010fold) than AZD6244. Inhibition of proliferation induced by AS703026 was mediated by G<jats:sub>0<\/jats:sub>\u2010G<jats:sub>1<\/jats:sub> cell cycle arrest and was accompanied by reduction of <jats:italic>MAF<\/jats:italic> oncogene expression. AS703026 further induced apoptosis via caspase 3 and Poly ADP ribose polymerase (PARP) cleavage in MM cells, both in the presence or absence of bone marrow stromal cells (BMSCs). Importantly, AS703026 sensitized MM cells to a broad spectrum of conventional (dexamethasone, melphalan), novel or emerging (lenalidomide, perifosine, bortezomib, rapamycin) anti\u2010MM therapies. Significant tumour growth reduction in AS703026\u2010 vs. vehicle\u2010treated mice bearing H929 MM xenograft tumours correlated with downregulated pERK1\/2, induced PARP cleavage, and decreased microvessels <jats:italic>in vivo<\/jats:italic>. Moreover, AS703026 (&lt;200\u2003nmol\/l) was cytotoxic against the majority of tumour cells tested from patients with relapsed and refractory MM (84%), regardless of mutational status of <jats:italic>RAS<\/jats:italic> and <jats:italic>BRAF<\/jats:italic> genes. Importantly, BMSC\u2010induced viability of MM patient cells was similarly blocked within the same dose range. Our results therefore support clinical evaluation of AS703026, alone or in combination with other anti\u2010MM agents, to improve patient outcome.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08127.x","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T09:14:54Z","timestamp":1268385294000},"page":"537-549","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Blockade of the MEK\/ERK signalling cascade by AS703026, a novel selective MEK1\/2 inhibitor, induces pleiotropic anti\u2010myeloma activity <i>in vitro<\/i> and <i>in vivo<\/i>"],"prefix":"10.1111","volume":"149","author":[{"given":"Kihyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun\u2010Young","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Fulciniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabikun","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew J.","family":"Rumizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Podar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharminder","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teru","family":"Hideshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Goutopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rastelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2010Tzu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,25]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4956"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0795"},{"key":"e_1_2_8_4_1","first-page":"3640","article-title":"Introduction of an activated N\u2010ras oncogene alters the growth characteristics of the interleukin 6\u2010dependent myeloma cell line ANBL6","volume":"55","author":"Billadeau D.","year":"1995","journal-title":"Cancer Research"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403116"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200075"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.729"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.142"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802353591"},{"key":"e_1_2_8_10_1","volume-title":"Proceedings of the 100th Annual Meeting of the American Association for Cancer Research","author":"Clark A.M.","year":"2009"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V81.10.2708.2708","article-title":"Mutational activation of N\u2010 and K\u2010ras oncogenes in plasma cell dyscrasias","volume":"81","author":"Corradini P.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4790"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403269"},{"key":"e_1_2_8_15_1","volume-title":"Proceedings of the 100th Annual Meeting of the American Association for Cancer Research","author":"Goutopoulos A.","year":"2009"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0037"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3434"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2189"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3926"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2640"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(04)00019-4"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.801"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1555"},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood.V88.7.2699.bloodjournal8872699","article-title":"Activating mutations of N\u2010 and K\u2010ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial","volume":"88","author":"Liu P.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_8_25_1","volume-title":"Proceedings of the 100th Annual Meeting of the American Association for Cancer Research","author":"Machl A.W.","year":"2009"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601613"},{"key":"e_1_2_8_27_1","first-page":"2539","article-title":"p53 and RAS gene mutations in multiple myeloma","volume":"7","author":"Portier M.","year":"1992","journal-title":"Oncogene"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/157488707780599393"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0833"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8851"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196238"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1503"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2419"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.362"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04304"},{"key":"e_1_2_8_36_1","first-page":"5850","article-title":"Insulin\u2010like growth factor\u20101 induces adhesion and migration in human multiple myeloma cells via activation of beta1\u2010integrin and phosphatidylinositol 3\u2032\u2010kinase\/AKT signaling","volume":"63","author":"Tai Y.T.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3630"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-4125"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-081240"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-107292"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-183772"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.4"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08127.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08127.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:30:41Z","timestamp":1697412641000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08127.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,25]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08127.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08127.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,25]]},"assertion":[{"value":"2010-04-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}